You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/75350
Title: 
Índice preditor de reserva ovariana (ORPI) para controle de estimulação ovariana individualizado
Other Titles: 
Expand evaluation of the ovarian response prediction index (ORPI) for individualised controlled ovarian stimulation
Author(s): 
Institution: 
  • Centre for Human Reproduction Prof. Franco Junior
  • Paulista Centre for Diagnosis, Research and Training
  • Universidade Estadual Paulista (UNESP)
  • Perola Byington Hospital
ISSN: 
  • 1517-5693
  • 1518-0557
Abstract: 
Objective: to expand the evaluation of a new ovarian response prediction index (ORPI), which was based on the AMH, AFC and age, and to verify its reability as a predictor of ovarian response to stimulation in assisted reproductive technology (ART) cycles. Methods: A total of 129 patients enrolled in the ICSI programme were included. The ORPI values were calculated by multiplying the AMH level (ng/ml) by the number of antral follicles (2-9 mm), and the result was divided by the age (years) of the patient (ORPI=(AMH × AFC)/Patient age). Results: Spearman's test revealed significant correlations (P<0.0001) between the ORPI and the number of oocytes collected and the number of follicles. Logistic regression revealed that ORPI values were significantly associated with the likelihood of collecting ≥4 oocytes (OR=45.56), ≥4 MII oocytes (OR=6.01) and ≥15 oocytes (OR=6.15; P<0.0001). Based on the ROC curves, the ORPI accurately predicted a low ovarian response (<4 oocytes retrieved; area under the curve (AUC):0.91), collection of ≥4 MII oocytes (AUC:0.85) and an excessive ovarian response (≥15 oocytes retrieved; AUC:0.89). Conclusions: The ORPI exhibited an excellent ability to predict a low ovarian response and a good ability to predict a collection of ≥ 4 MII oocytes, an excessive ovarian response. The ORPI might be used to improve the cost-benefit ratio of ovarian stimulation regimens by guiding the selection of medications and by modulating the doses and regimens according to the actual needs of the patients. © Todos os direitos reservados a SBRA - Sociedade Brasileira de Reprodução Assistida.
Issue Date: 
3-May-2013
Citation: 
Jornal Brasileiro de Reproducao Assistida, v. 17, n. 2, p. 77-83, 2013.
Time Duration: 
77-83
Keywords: 
  • Age
  • Anti-Mullerian hormone
  • Antral follicles
  • Individualized controlled ovarian stimulation
  • Ovarian response prediction index
  • cetrorelix
  • chorionic gonadotropin
  • leuprorelin
  • luteinizing hormone
  • Muellerian inhibiting factor
  • recombinant follitropin
  • adult
  • age
  • cost benefit analysis
  • drug dose increase
  • female
  • human
  • major clinical study
  • named inventories, questionnaires and rating scales
  • oocyte
  • ovarian response prediction index
  • ovary follicle
  • ovary function
  • transvaginal echography
URI: 
Access Rights: 
Acesso restrito
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/75350
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.